JP2017529377A5 - - Google Patents

Download PDF

Info

Publication number
JP2017529377A5
JP2017529377A5 JP2017516659A JP2017516659A JP2017529377A5 JP 2017529377 A5 JP2017529377 A5 JP 2017529377A5 JP 2017516659 A JP2017516659 A JP 2017516659A JP 2017516659 A JP2017516659 A JP 2017516659A JP 2017529377 A5 JP2017529377 A5 JP 2017529377A5
Authority
JP
Japan
Prior art keywords
foam
forming
body cavity
pharmaceutical composition
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017516659A
Other languages
English (en)
Japanese (ja)
Other versions
JP6659674B2 (ja
JP2017529377A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2015/051011 external-priority patent/WO2016048230A1/en
Publication of JP2017529377A publication Critical patent/JP2017529377A/ja
Publication of JP2017529377A5 publication Critical patent/JP2017529377A5/ja
Application granted granted Critical
Publication of JP6659674B2 publication Critical patent/JP6659674B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017516659A 2014-09-25 2015-09-25 泡沫形成組成物、及び活性剤を体腔に送達するための方法 Expired - Fee Related JP6659674B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462055001P 2014-09-25 2014-09-25
US62/055,001 2014-09-25
PCT/SE2015/051011 WO2016048230A1 (en) 2014-09-25 2015-09-25 Foam-forming compositions and methods for delivering an active agent to a body cavity

Publications (3)

Publication Number Publication Date
JP2017529377A JP2017529377A (ja) 2017-10-05
JP2017529377A5 true JP2017529377A5 (enExample) 2018-10-11
JP6659674B2 JP6659674B2 (ja) 2020-03-04

Family

ID=55581573

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017516659A Expired - Fee Related JP6659674B2 (ja) 2014-09-25 2015-09-25 泡沫形成組成物、及び活性剤を体腔に送達するための方法

Country Status (16)

Country Link
US (1) US9895311B2 (enExample)
EP (2) EP3197431B1 (enExample)
JP (1) JP6659674B2 (enExample)
KR (1) KR102569954B1 (enExample)
CN (1) CN106687109B (enExample)
AU (1) AU2015322112B2 (enExample)
BR (1) BR112017006154B1 (enExample)
CA (1) CA2959717C (enExample)
DK (1) DK3197431T3 (enExample)
ES (1) ES2946510T3 (enExample)
FI (1) FI3197431T3 (enExample)
HU (1) HUE062224T2 (enExample)
PL (1) PL3197431T3 (enExample)
PT (1) PT3197431T (enExample)
RU (1) RU2710019C2 (enExample)
WO (1) WO2016048230A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
EP3481401A4 (en) * 2016-07-11 2020-03-11 Hennepin Life Sciences, LLC COMPOSITIONS FOR SEXUALLY TRANSMITTED DISEASES
WO2018215474A1 (en) * 2017-05-23 2018-11-29 Pharmiva Ab Foam-forming compositions for delivering an active to a body cavity
KR20240036492A (ko) 2021-01-27 2024-03-20 펩토닉 메디컬 에이비 생물막 분해 또는 생물막 형성 방지에 사용하기 위한 조성물
CA3175700A1 (en) * 2021-06-11 2022-12-11 Ankh Life Sciences Limited Lipid crystalline compositions with enhanced stability for topical delivery of active agent combinations

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684479A (en) 1985-08-14 1987-08-04 Arrigo Joseph S D Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures
SE454397B (sv) * 1985-12-20 1988-05-02 Biogram Ab Stabiliserad vattenbaserad antimikrobiell veteperoxidkomposition, forfarande for framstellning derav samt anvendning derav som antimikrobiell spendoppningskomposition for mjolkproducerande djur
JPH06279228A (ja) 1993-03-30 1994-10-04 Kao Corp 発泡性組成物
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
JPH07197083A (ja) 1993-12-28 1995-08-01 Kao Corp 洗浄剤組成物
US5741525A (en) 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
US5778886A (en) 1996-02-27 1998-07-14 Shihata; Alfred Vaginal compositions combining a spermicidal agent and a peroxygen compound
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US20020031556A1 (en) * 2000-07-21 2002-03-14 Lindahl Ake R. Stabilized hydrogen peroxide composition and method of making a stabilized hydrogen peroxide composition
US7709026B2 (en) 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
EA014372B1 (ru) 2003-01-24 2010-10-29 Стифел Рисерч Оустрэйлиа Пти Лтд. Пена на основе фосфата клиндамицина
US8193244B1 (en) 2008-05-29 2012-06-05 Nevada Naturals, Inc. Antimicrobial agents
US20040197270A1 (en) 2003-04-01 2004-10-07 Mundschenk David D. Topical formulations and delivery systems
CA2536482C (en) * 2003-08-25 2012-07-24 Foamix Ltd. Penetrating pharmaceutical foam
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
WO2006131784A1 (en) 2004-04-28 2006-12-14 Foamix Ltd. Body cavity foams
JP2008533048A (ja) 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 耳の感染症の治療方法
US20070299043A1 (en) * 2005-10-03 2007-12-27 Hunter William L Anti-scarring drug combinations and use thereof
JP2009522003A (ja) * 2005-12-29 2009-06-11 スリーエム イノベイティブ プロパティズ カンパニー 発泡性歯科用組成物及び方法
WO2008075207A2 (en) 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
WO2008110872A2 (en) * 2006-06-23 2008-09-18 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
HRP20140559T1 (hr) * 2007-03-30 2014-08-01 Laccure Ab Uporaba oligomera mlijeäśne kiseline u lijeäśenju ginekoloških infekcija
EP2020221B1 (de) * 2007-06-19 2012-02-29 Neubourg Skin Care GmbH & Co. KG DMS (Derma Membrane Structure) in Schaum-Cremes
US20090239954A1 (en) * 2008-03-19 2009-09-24 Collins Gary L Phosphate buffered ophthalmic solutions displaying improved efficacy
EP2482788B1 (en) 2009-10-02 2022-12-14 Journey Medical Corporation Topical tetracycline compositions
US8414868B2 (en) * 2010-02-04 2013-04-09 Ultradent Products, Inc. In situ foamable dental bleaching compositions and methods, systems and kits for bleaching teeth using such compositions
WO2014175814A1 (en) * 2013-04-26 2014-10-30 Bioglan Ab Composition for use in reducing scab formation and promoting healing
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity

Similar Documents

Publication Publication Date Title
JP2023017050A5 (enExample)
US20250186514A1 (en) Ammonia oxidizing microorganisms for use and delivery to the urogenital system
RU2017112055A (ru) Пенообразующие композиции и способы доставки активного агента в полость тела
CN105142612A (zh) 用于直肠给药的药物组合物
JP2014500257A5 (enExample)
CN101642467A (zh) 长效消毒膏
FI3628002T3 (fi) Vaahtoa muodostavat koostumukset aktiivisen aineen kuljettamiseksi kehon onteloon
JP2013519695A5 (enExample)
RU2018125252A (ru) Синергическая комбинация пирролидонкарбоновой кислоты и/или ее солей и гиалуроновой кислоты и/или ее солей для применения в лечении и/или профилактике сухости и раздражения слизистых оболочек, и связанные фармацевтические композиции
JP6857644B2 (ja) 直腸の炎症性変化の治療用医薬製剤
OA20623A (en) Foam-forming compositions for delivering an active to a body cavity.
OA18854A (en) Foam-Forming Compositions and Methods for Delivering an Active Agent to a Body Cavity
HK40017987A (en) Foam-forming compositions for delivering an active to a body cavity
HK1242202B (en) Foam-forming compositions and methods for delivering an active agent to a body cavity